Travis C. Mickle's most recent trade in Zevra Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $4.4 . Disclosure was reported to the exchange on May 25, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 25 May 2022 | 10,000 | 11,034 (0%) | 0% | 4.4 | 43,900 | Common Stock |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.36 per share. | 25 May 2022 | 2,000 | 38,521 (0%) | 0% | 4.4 | 8,711 | Common Stock |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 25 May 2022 | 1,000 | 39,521 (0%) | 0% | 4.4 | 4,385 | Common Stock |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 267,156 | 267,156 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 8.23 per share. | 18 Nov 2021 | 2,250 | 36,521 (0%) | 0% | 8.2 | 18,516 | Common Stock |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 8.92 per share. | 30 Aug 2021 | 5,000 | 34,271 (0%) | 0% | 8.9 | 44,608 | Common Stock |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 263,743 | 263,743 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 96,153 | 23,354 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 96,153 | 96,153 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 7,701 | 0 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 7,701 | 31,055 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 6,287 | 0 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 3,125 | 29,271 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 1,341 | 0 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2021 | 1,341 | 32,396 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Travis C. Mickle | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 14.43 per share. | 14 Jun 2021 | 1,500 | 119,507 (0%) | 0% | 14.4 | 21,645 | Common Stock |